Central to intrinsic apoptosis signaling is the release of cytochrome c from mitochondria, which depends on the pro-apoptotic effector proteins Bax, Bak or Bok. These pore-forming effector proteins share four Bcl-2 homology (BH) domains, a functionally essential and conserved sequence of hydrophobic amino acids in their BH3-domain and a C-terminal transmembrane-domain whose specific function remains rather unknown. To elucidate the molecular basis of Bok-mediated apoptosis we analyzed apoptosis induction by transmembrane-domain deficient BokΔTM compared to the respective Bax and Bak proteins and proteins in which the first leucine in the BH3-stretch was mutated to glutamic acid. We show that deletion of the C-terminal transmembrane-domain reduces the pro-apoptotic function of each protein. Mutation of the first leucine in the BH3-domain (L78E) blocks activity of Bak, while mutation of the homologue residues in Bax or Bok (L63E and L70E respectively) does not affect apoptosis induction. Unexpectedly, combined mutation of the BH3-domain and deletion of the transmembrane-domain enhances the pro-apoptotic activity of Bok(L70E)ΔTM by abolishing the interaction with anti-apoptotic proteins, especially the primary Bok-inhibitory protein Mcl-1. These results therefore suggest a specific contribution of the transmembrane-domain to the pro-apoptotic function and interaction of Bok.
Results
Apoptosis induction by Bax, Bak, and Bok. Discrepancies in published data regarding the pro-apoptotic activity of Bok and its regulation encouraged us to compare the effect of Bok overexpression to that of Bax and Bak. We transfected HEK293T cells with vectors for the expression of EGFP fusion proteins of Bax, Bak and Bok. We harvested HEK293T cells 18 h post transfection and detected cell death by flow cytometric analysis of SytoxRed stained cells ( Fig. 1A) . As expected, overexpression of each of the multidomain proteins efficiently induced cell death in HEK293T cells, i.e. Bax (30%), Bak (25%) and Bok (20%). Importantly, in HEK293T cells there was no significant difference in cell death induction by Bok as compared to Bak. To further prove that cells die via apoptosis we performed identical experiments and investigated apoptosis associated exposure of phosphatidylserine by labeling cells 12 h, 18 h and 24 h post transfection with Annexin-V-APC. Subsequent flow cytometric analysis showed that each of the multidomain proteins efficiently induced exposure of phosphatidylserine at different time points in 45-55% (Bax), 35-55% (Bak), and 30-40% (Bok) of transfected cells showing slight differences in kinetics ( Fig. 1B) . We additionally assessed loss of the mitochondrial membrane potential in transfected cells by TMRE staining. Overexpression of each of the MDPs induced depolarization of mitochondria; the proportion of cells with low mitochondrial membrane potential at the indicated time points was 50-60% (Bax), 50-70% (Bak), or 40% (Bok) (Fig. 1C ).
Having shown that the EGFP-fusion proteins of Bax, Bak and Bok induce apoptosis to a comparable extent in Bax and Bak proficient HEK293T cells we next investigated whether the MDPs also induce apoptosis in baby mouse kidney cells (BMK) from Bax −/− /Bak −/− double knock out (DKO) mice. In line with recently published data 6 overexpression of EGFP-fusion proteins of Bax, Bak and also Bok efficiently induced cell death in these BMK/DKO cells (Bax: 40%/; Bak: 55%; Bok: 40%) (SytoxRed + , Fig. 1D ). Expression of EGFP-fused MDPs also induced exposure of phosphatidylserine (Annexin-V + ; Fig. 1E ) and dissipation of the mitochondrial membrane potential (TMRE LOW ; Fig. 1F ) in BMK cells at the indicated time points.
Hence, in BMK cells Bok induces apoptosis independently of Bax and Bak whereas it was proposed to depend on the presence of Bax or Bak in HCT116 cells 14 . To prove independent apoptosis induction by Bok we repeated the experiments in Bax&Bak proficient (WT) and deficient (DKO) HCT116 cells. We found that each multidomain protein readily induced apoptosis in both cell lines, HCT116/WT and HCT116/DKO ( Fig. 2A) . Clearly, Bok does not rely on another pro-apoptotic MDP to induce apoptosis. However, apoptosis induction was reduced SCiEnTiFiC RepoRts | (2018) 8:12434 | DOI:10.1038/s41598-018-30603-6 in HCT116/DKO as compared to HCT116/WT, indicating that endogenously expressed Bax and Bak reinforce apoptosis induction by MDP overexpression. We further corroborated these data by analyzing loss of mitochondrial membrane potential in transfected HCT116/WT and HCT116/DKO cells. To this end TMRE stained cells were analyzed by flow cytometry. The results show that overexpression of each MDP induced dissipation of the mitochondrial membrane potential in both cell lines ( Fig. 2B ). Exposure of phosphatidylserine (PS) and dissipation of the mitochondrial membrane potential was more efficiently induced in the presence of endogenous Bax and Bak (HCT116/WT) than in the Bax&Bak deficient HCT116/DKO. These results unambiguously establish that Bok induces loss of mitochondrial membrane potential and apoptosis in the absence of another pro-apoptotic multidomain protein. The discrepancy to published data, i.e. non-autonomous apoptosis induction by Bok in MEF/DKO, most likely is due to the expression level of Bok in combination with the expression level of anti-apoptotic (Bcl-2 like) proteins, such as Mcl-1. 15 . In order to clarify whether or not Mcl-1 counteracts Bok's pro-apoptotic activity we co-transfected HEK293T cells with vectors for the expression of EGFP-fused Bax, Bak or Bok together with expression constructs for Flag-tagged Mcl-1 and then stained cells with TMRE and Annexin-V-APC for flow cytometric analysis. Mcl-1 significantly reduced induction of cell death ( Fig. S1A left panel) and loss of mitochondrial membrane potential ( Fig. S1A right panel) induced by its interaction partner Bak, and attenuated the function of Bax and Bok. Hence, we assumed the involvement of downstream activation of Bak in HEK293T. In order to discriminate interaction of overexpressed and endogenous MDPs with transgenic Mcl-1 we changed the experimental system and transfected HCT116/WT as control and HCT116/DKO cells with expression vectors for EGFP-tagged MDP proteins Bax, Bak and Bok together with expression constructs for N-terminally Flag-tagged Mcl-1.
Mcl-1 counteracts apoptosis induction by
MDP expression induced exposure of Annexin-V and loss of mitochondrial membrane potential in HCT116/ WT and, HCT116/DKO cells ( Fig. 2B ). Co-expression of Mcl-1 reduced apoptosis induction by Bak and to a 
Impact of TM-deletion on apoptosis induction by MDPs. Having established inhibition of
Bok-induced apoptosis by Mcl-1 we next investigated the molecular basis for Bok mediated apoptosis with regard to structural premises. We transfected cells with a vector for the expression of Bok variant that is deficient in the C-terminal transmembrane-domain (ΔTM). Again, we included BaxΔTM and BakΔTM in order to conclude on similarities or differences in the mechanism of apoptotsis induction. Transfection of HCT116/WT and HCT116/ DKO and flow cytometric analysis of EGFP + cells revealed, compared to the respective full length (FL) protein, a reduced proportions of Annexin-V + HCT116/WT cells upon expression of BaxΔTM (60% vs. 40%), BakΔTM (70% vs. 50%) and BokΔTM (30% vs. 20%) ( Fig. 3A , left panel). In HCT116/DKO the decrease of apoptotic cells due to deletion of the transmembrane-domain was more pronounced: BaxΔTM (50% vs. 25%), BakΔTM (65% vs. 20%) and BokΔTM (20% vs. 10%) ( Fig. 3A, right panel) . Accordingly, dissipation of the mitochondrial membrane potential by BaxΔTM, BakΔTM or BokΔTM was significantly reduced as compared to FL proteins both, in HCT116/WT and most distinctive in HCT116/DKO ( Fig. 3B ). We conclude that the transmembrane-domain has a significant impact on the pro-apoptotic potential of each multidomain protein, most prominently for the membrane localized Bak and slightly less pronounced in case of Bax and Bok. Impact of BH3 mutation on apoptosis induction by MDPs. The pro-apoptotic activity of MDP proteins also depends on their BH3-domain [19] [20] [21] . The α-helical BH3-domain (α2-helix) is highly conserved among Bcl-2 proteins and is characterized by hydrophobic residues that face in the same direction 22 and thereby can mediate binding to the hydrophobic groove of Bcl-2 proteins 23 . Mutation of (the first) conserved hydrophobic amino acid in Bak 19 and Bax 20 results in decreased apoptosis induction because the BH3-domain is involved in homo-oligomerization 21 . Indeed, highly sophisticated mutational analyses revealed that the BH3-domain mediates Bax dimerization 24 . To analyze the role of the BH3-domain in Bok-induced apoptosis we transfected expression vectors for BH3-mutant Bax(L63E), Bak(L78E) and Bok(L70E) in HCT116/WT and HCT116/DKO cells and analyzed apoptosis induction (Annexin-V binding) and loss of ΔΨm (decreased TMRE fluorescence) by flow cytometry. Expectedly, we found reduced apoptosis induction by Bax(L63E) (62% to 42% in WT; 48% to 33% in DKO) and almost abolished cell death induction by Bak(L78E) (73% to 23% in WT; 66% to 13% in DKO; Fig. 3C ). In contrast, apoptosis induction by Bok(L70E) was not reduced compared to Bok (34% to 38% in WT; 25% to 27% in DKO; Fig. 3C ). Similarly, overexpression of Bax(L63E) showed attenuated dissipation of the mitochondrial membrane potential (67% to 57% in WT; 52% to 32% in DKO) and Bak(L78E) almost completely failed to induce loss of ΔΨm (83% to 19% in WT; 76% to 11% in DKO), compared to the respective WT proteins. Surprisingly and in contrast to Bax and Bak, Bok(L70E) induced loss of ΔΨm as efficiently as wildtype Bok (33% to 39% in WT; 24% to 27% in DKO) ( Fig. 3D ).
Enhanced apoptosis induction by Bok(L70E)ΔTM. Deletion of the TM reduced apoptosis induction
by each multidomain protein, including Bok, whereas BH3 mutation reduced Bax-and abolished Bak-induced apoptosis but did not affect activity of Bok. We next asked whether the combined deletion of TM and mutation of BH3 would further reduce the activity of EGFP-tagged Bax, Bak or Bok. Upon expression of the respective proteins, FACS analysis showed that Bax-induced apoptosis is strongly reduced by the L63E mutation in combination with the deletion of the TM ( 
Determinants of Bok and Mcl-1 interaction.
To investigate the localization of Bok and the interaction of Bok with Mcl-1 we performed immunofluorescence microscopy in MCF7 cells because of their inherent apoptosis resistance downstream of MOMP due to caspase-3 deficiency 25 . In control experiments overexpression of EGFP-Bak together with mCherry-Mcl-1 readily showed localization of EGFP-Bak at mitochondria and co-localization of EGFP-Bak with mCherry-Mcl-1 (Fig. 5A) . Similarly, EGFP-Bok localized to mitochondria and co-localized with mCherry-Mcl-1 (Fig. 5B ). Because co-localization is a prerequisite for protein-protein interaction but does not prove binding of Bok to Mcl-1 we performed fluorescence/Förster resonance energy transfer (FRET) fluorescence lifetime imaging (FLIM) analysis. In FRET-FLIM analysis the fluorescence lifetime of the FRET-donor (EGFP) is reduced in case a FRET-acceptor (mCherry) is in very close proximity. We transfected MCF7 cells with vectors for the expression of EGFP-Bak or EGFP-Bok alone (as control) and in combination with mCherry-Mcl-1. FRET/FLIM analysis revealed a fluorescence lifetime of τ = 2.36 ± 0.04 ns for EGFP-Bak that was shortened to τ = 2.11 ± 0.03 ns in the presence of its mCherry-tagged binding partner Mcl-1 (Fig. 5C ). The fluorescence lifetime of EGFP-Bok was τ = 2.34 ± 0.06 ns and comparably reduced by 0.20 ns in the presence of mCherry-Mcl-1 (τ = 2.14 ± 0.12 ns, Fig. 5D ). These results strongly indicate direct interaction of Bok with Mcl-1. Confirming these data, also FRET/FLIM analysis in HCT116/DKO showed that the fluorescence lifetime of EGFP-Bok was reduced from τ = 2.14 ± 0.11 ns in the absence to τ = 1.91 ± 0.12 ns in the presence of mCherry-Mcl-1 (Fig. 5E ). Hence, also in a Bax&Bak deficient system a direct interaction of Bok and Mcl-1 (Fig. 5F) . We furthermore measured also in Bax&Bak deficient BMK cells co-transfected with mCherry-Mcl-1 a shorter lifetime of τ = 2.19 ± 0.12 ns for EGFP-Bok than for EGFP-Bok(L70E)ΔTM (τ = 2.39 ± 0.26 ns; Fig. S2A ). Finally, we tested whether the interaction of Bok and Mcl-1 also depends on the TM-domain of Mcl-1. To this end we analyzed MCF7 cells expressing EGFP-Bok alone, EGFP-Bok or 
Discussion
In the past 30 years highly sophisticated analyses have disclosed numerous details of how members of the Bcl-2 family regulate apoptosis in a complex network of specific interactions. The downstream effectors of the Bcl-2 network, i.e. Bax and Bak, undergo a series of distinct conformational changes and finally permeabilize the mitochondrial outer membrane by forming oligomeric structures 3 . The Bax/Bak homologous protein Bok however, seems to withstand consistent characterization 26 as seemingly conflicting results are published regarding its ability to autonomously induce apoptosis and the interaction of Bok with anti-apoptotic proteins, such as Mcl-1. Echeverry et al. 14 model systems, i.e. MEF (Echeverry) or BMK (baby mouse kidney cells, Einsele-Scholz) from Bax/Bak double knock out mice or HCT116/DKO cells 18 . Also, Bok was either inducibly expressed (Echeverry: 4-OHT, Llambi: Doxycycline) or controlled by a CMV-promotor. It is conceivable that the expression level achieved by inducible expression does not overcome the threshold of endogenously expressed anti-apoptotic proteins -especially in the absence of Bax and Bak. In this line, the potential criticism addressed at the non-physiological nature of overexpression is not applicable in case of overexpression in knock-out models, as KO-models do not display a physiological background themself. Self-evidently, Bok induces apoptosis more efficiently in the presence of Bax and Bak than in their absence -due to co-operative action or a reduced threshold of free anti-apoptotic proteins. However, the same is true for overexpressed Bax and to some extent also for Bak, as shown in Figs 1-4 .
Here, we investigated whether the presence of anti-apoptotic proteins counteracts Bok-induced apoptosis and found that co-expression of the anti-apoptotic proteins Bcl-2 or Bcl-xL did not reduce Bok-induced apoptosis (not shown). In contrast, Mcl-1, that served as bait in the yeast two hybrid screen that identified Bok 11 , clearly reduced Bok-induced apoptosis. In order to dissect structural similarities and differences between Bax, Bak and Bok we analyzed induction of apoptosis upon expression of TM-deficient variants of these proteins. These experiments show that deletion of the TM-domain reduces the pro-apoptotic capacity of all three proteins. In this regard, Bok functions similar to Bax rather than Bak that shows reduced but not abolished pro-apoptotic activity upon removal of the TM-domain. Mutation of the conserved hydrophobic leucine in the BH3-domain reduced apoptosis induction by Bax and Bak, but unexpectedly had negligible impact on Bok-induced MOMP and apoptosis, indicating that Bok(L70E) still oligomerizes and forms pores. Despite these data underlining the structural and functional similarity of Bok to Bax and Bak, it is especially puzzling that simultaneous mutation of L70E and deletion of the transmembrane-domain enhanced rather than abolished apoptosis induction by Bok(L70E) ΔTM. The reason for this unexpected finding likely is that inhibition of Bok by Mcl-1 is not only mediated by the BH3-domain but also the TM-domain. This would mean that mutation of L70E reduces interaction of Bok The proposed TM-domain-mediated interaction is further corroborated by FRET/FLIM data showing that Bok(L70E)ΔTM, in contrast to Bok, is not localized in close proximity to Mcl-1 (Fig. S2) . A contribution of the TM-domain to the interaction with its anti-apoptotic binding partner was also shown for Bax and Bcl-2 28 . Interaction via the TM-domain would also explain co-precipitation with Mcl-1 15 despite a rather low binding constant of the Bok-BH3 peptide for Mcl-1. Assuming structural similarity, the oligomerization of Bax-dimers by TM-domain interaction 24 appears to be dispensable meaning that additional interaction via e.g. α1:α1, α3:α5 and α6:α6 would drive multimerization of BokΔTM (or BaxΔTM) 24, 29, 30 .
However, we propose that interaction of Bok with Mcl-1 is mediated both, by the TM-domain (α9) and the BH3-domain (α2). A schematic representation of the generalized model illustrates the interaction of effector/ pore former MDPs and anti-apoptotic "Bcl-2" proteins via BH3/BC-groove binding and TM-domain interaction (Fig. 6 ). Our data clearly show that Bok mediates apoptosis in the absence of Bax and Bak. The discrepancy in the conclusion whether Bok autonomously induces cytochrome c release 6 or is only capable to do so in the presence of Bax or Bak 14 most likely is due to different expression levels of Bok in the context of varying disposable anti-apoptotic Bcl-2 proteins, especially Mcl-1. It is noteworthy to mention that Mcl-1 is quickly degraded by the proteasome 16, 17 and the stabilization of Bok by proteasome inhibitors 15 therefore might be an indirect effect due to binding to Mcl-1. Similarly, stabilization of Mcl-1 is seen when the BH3-only proteins Puma 31 or Nbk/Bik are overexpressed 4 . In case of the investigated experimental system using overexpression of GFP-fusion proteins it is worth to mention that inhibition of the proteasome by MG132 only marginally influences the expression level of GFP-Bok variants (Fig. S3A) whereas inhibition of caspase-activity, i.e. apoptosis, by Q-VD-OPh results in massively enhanced expression levels, especially of apoptosis inducing GFP-fused Bok variants (Fig. S3B) . Also, the expression level of endogenous Bok is only slightly enhanced by different concentrations of MG132 after 8 h and 24 h whereas Mcl-1 expression levels are strongly increased at lowest concentration (Fig. S3C ). In line with proteasomal degradation of endogenous Mcl-1 also the expression level of GFP-Mcl-1 is enhanced by MG132 whereas GFP-Bok expression is only marginally affected (Fig. S3D) . Finally, the reduced detection of apoptosis inducing-proteins as compared to inactive-variants ( Fig. S4A,B) is commonly seen and likely reflects apoptosis-associated reduced expression and/or protein loss due to permeabilization of the plasma membrane in secondary necrosis.
Although there are still some things about Bok we just don't get 32 it is likely that the seemingly incongruent results arise from the lacking incorporation of additional parameters of the different experimental systems, e.g. expression level of investigated proteins, especially in view of the dynamic nature of protein interactions. Looking at the long winding path to the development of solid models for the regulation of Bax and Bak activity 33 that finally take relevant biochemical parameters, i.e. binding constants, into account, we are confident that comprehensive and more sophisticated analyses also will reveal the true nature of Bok in apoptosis. Western blot. Cells were harvested by scraping, lysed in lysis buffer (1% Triton X-100, 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM MgCl2 and 5 mM EDTA, pH 8.0) and relative protein content was assayed using the BCA protein assay (Pierce). Equal amounts of protein (30 µg) were separated in an SDS-polyacrylamide gel and transferred to nitrocellulose membrane using semi-dry blotting. Membranes were blocked in PBS/0.05% Tween20 (PBS-T) containing 5% BSA and incubated with primary antibody (0.2 μg/mL) in PBS-T/5% BSA at 4 °C over night. After washing thrice membranes were incubated with species specific horseradish peroxidase coupled antibody (Jackson Laboratories) in PBS-T/5% BSA for 2 h with shaking, washed in PBS-T and specific bands were visualized by enhanced chemiluminescence. Pictures were taken using the Fusion FX System (PeqLab) until sufficient pixel saturation was achieved or using x-ray films.
Materials and Methods

Chemicals and antibodies.
All chemicals were purchased in pro analysi grade from Merck KGaA (Germany) or Carl Roth GmbH. Antibodies for western blot were rabbit anti-Bok (Abcam; EPR15331), mouse anti-GFP (BioLegend; Clone B34) and rabbit anti-Tom20 (Santa Cruz Biotechnology; FL-145), mouse anti-β-actin (Sigma; clone AC74), anti-Mcl-1 (Santa Cruz Biotechnology, H-260) anti-mouse-HRP and anti-rabbit-HRP (Jackson Laboratories).
Immunofluorescence microscopy and FRET/FLIM analysis. Cells were seeded on coverslips or in chamberslides 24 h prior to transfection. Immediately before transfection with the indicated plasmids for the expression of EGFP-and/or mCherry-fusion proteins culture medium was replaced by fresh medium SCiEnTiFiC RepoRts | (2018) 8:12434 | DOI:10.1038/s41598-018-30603-6 supplemented with 10 µM Q-VD-OPh (MP Biomedicals). After 18 h or 20 h transfected cells were fixed in PBS/4% H 2 CO for 20 min. at room temperature and washed in cold PBS. For immunofluorescence microscopy fixed cells were incubated in specific antibody diluted in PBS/0.05% Saponin/5% BSA over night at 4 °C. Samples were washed in PBS two times and then incubated with species specific secondary antibody coupled to Alexafluor-405 or Alexafluor-633. Finally, samples were washed in PBS and mounted on coverslides.
For FRET/FLIM analysis coverslips were equilibrated in Na-phosphate buffer pH 8.5 and mounted using mounting medium (DAKO). Cells in chamberslides were stored in PBS/Tris (pH 8.5). The measurements were performed using a TCS SP8 confocal laser scanning microscope (Leica Microsystems) with LAS X and SymPhoTime software. Before the FRET-FLIM measurement, the presence of the fluorophores was detected using 488 and 561 nm lasers for GFP and mCherry excitation, respectively. The fluorescence lifetime (FLT) [ns] of either the donor only expressing cells or the donor-acceptor pairs was measured by excitation with a 470 nm pulsed laser at a repetition rate of 40 MHz (PicoQuant Sepia multichannel picosecond diode laser, PicoQuant Picoharp 300 TCSPC module, and Picosecond event timer). For each sample 500 photons in the brightest pixel of at least 7 cells each were acquired. Data processing was performed with SymPhoTime software for curve fitting, correction for the instrument response function, and a limited fitting range from channel 0 to 20 ns to obtain the GFP fluorescence lifetime.
Data availability. No datasets were generated or analyzed during the current study.
